A link between p73 transcriptional activity and p73 degradation

Oncogene

Volumn 23, Issue 22, 2004, Pages 4032-4036

  Wu, Liqing ^a   Zhu, Hongyan ^a   Nie, Linghu ^a   Maki, Carl G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Degradation; p53; p73

Indexed keywords

MUTANT PROTEIN; PROTEIN MDM2; PROTEIN P53; PROTEIN P63; PROTEIN P73; DNA BINDING PROTEIN; ISOPROTEIN; NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; CELL LINE; GENE DELETION; GENE FUSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN STABILITY; PROTEIN VARIANT; TURNOVER TIME; WILD TYPE; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; TUMOR SUPPRESSOR GENE;

ANIMALS; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 2542540517     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207538     Document Type: Article

References (25)

1. Balint E, Bates S and Vousden KH. (1999). Oncogene, 8, 3923-3929.
2. Boyd SD, Tsai KY and Jacks T. (2000). Nat. Cell Biol. 2, 563-568.
3. Candau R, Scolnick DM, Darpino P, Ying CY, Halazonetis TD and Berger SL. (1997). Oncogene, 15, 807-816.
4. Douc-Rasy S, Barrios M, Echeynne M, Kaghad M, Blanc E, Raguenez G, Goldschneider D, Terrier-Lacombe MJ, Hartmann O, Moll U, Caput D and Benard J. (2002). Am. J. Pathol., 160, 631-639.
5. Geyer RK, Yu ZK and Maki CG. (2000). Nat. Cell Biol., 2, 569-573.
6. Gu J, Chen D, Rosenblum J, Rubin RM and Yuan ZM. (2000). Mol. Cell. Biol., 20, 1243-1253.
7. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
8. Honda R, Tanaka H and Yasuda H. (1997). FEBS Lett., 420, 25-27.
9. Jost CA, Marin MC and Kaelin Jr WG. (1997). Nature, 389, 191-194.
10. Kadakia M, Slader C and Berberich SJ. (2001). DNA Cell Biol., 20, 321-330.
11. Kubbutat MH, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
12. Little NA and Jochemsen AG. (2001). Oncogene, 20, 4576-4580.
13. Lee CW and La Thangue NB. (1999). Oncogene, 18, 4171-4181.
14. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R and Benchimol S. (2003). Cell, 112, 779-791.
15. Melino G, De Laurenzi V and Vousden KH. (2002). Nat. Rev. Cancer, 2, 1-11.
16. Miyazaki K, Ozaki T, Kato C, Hanamoto T, Fujita T, Irino S, Watanabe K, Nakagawa T and Nakagawara A. (2003). Biochem. Biophys. Res. Commun., 308, 106-113.
17. Momand J, Zambetti GP, Olson DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
18. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B. (1993). Nature, 362, 857-860.
19. Takada N, Ozaki T, Ichimiya S, Todo S and Nakagawara A. (1999). Cancer Res., 59, 2810-2814.
20. Ueda Y, Hijikata M, Takagi S, Chiba T and Shimotohno K. (1999). Oncogene, 18, 4993-4998.
21. Yang A, Kaghad M, Caput D and McKeon F. (2002). Trends Genet., 18, 90-95.
22. Yang A and McKeon F. (2000). Nat. Rev. Mol. Cell Biol., 1, 199-207.
23. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E and Moll U. (2002). J. Exp. Med., 196, 765-780.
24. Zeng X, Chen L, Jost CA, Maya R, Keller D, Wang X, Kaelin Jr WG, Oren M, Chen J and Lu H. (1999). Mol. Cell. Biol., 19, 3257-3266.
25. Zhu J, Zhou W, Jiang J and Chen X. (1998). J. Biol. Chem., 273, 13030-13036.